Neftaly: Strategies for Transferring Biomarker Technologies to Low-Resource Settings
Biomarker technologies offer powerful insights into disease detection, progression, and prevention. However, ensuring that these innovations reach and benefit populations in low-resource settings requires thoughtful strategies and inclusive implementation. At Neftaly, we are committed to closing the innovation-access gap by developing and deploying practical approaches that make biomarker technologies usable, scalable, and sustainable where they are needed most.
Why Technology Transfer Matters
Many health challenges in low- and middle-income countries go undetected or untreated due to limited access to modern diagnostics. By transferring biomarker technologies, Neftaly helps enable:
- Early disease detection in hard-to-reach areas
- Faster public health responses during outbreaks
- Improved outcomes for chronic and infectious diseases
- Equitable access to scientific and medical advancements
Neftaly’s Key Strategies for Successful Technology Transfer
1. Contextual Adaptation
We adapt biomarker technologies to local realities, including:
- Using low-cost, rugged devices that function without continuous power or internet
- Adjusting test protocols for regional diseases and population health needs
- Translating materials and software into local languages
2. Capacity Building and Training
Neftaly invests in people as much as technology by:
- Training local healthcare workers, lab technicians, and data managers
- Supporting “train-the-trainer” models to build local expertise
- Creating accessible digital modules for continued education
3. Strengthening Local Infrastructure
We support the development of the systems needed to sustain technology use, including:
- Basic laboratory upgrades
- Sample transportation logistics
- Mobile health units for remote testing
- Cold-chain and data connectivity solutions where needed
4. Public-Private Partnerships
Neftaly facilitates partnerships with governments, academic institutions, NGOs, and manufacturers to:
- Share intellectual property through fair licensing agreements
- Support local production or assembly of diagnostic kits
- Promote regulatory alignment and technology adoption at scale
5. Affordable and Scalable Solutions
We prioritize technologies that are:
- Cost-effective for both procurement and long-term use
- Modular and scalable, so they can be integrated into existing systems
- Designed for point-of-care or field use, not just laboratories
6. Community Engagement
Neftaly involves communities in the technology transfer process by:
- Educating populations about the benefits of biomarker testing
- Addressing cultural concerns and ethical considerations
- Ensuring informed consent and respect for local values
7. Monitoring, Evaluation, and Continuous Support
To ensure long-term impact, Neftaly:
- Monitors uptake, effectiveness, and challenges post-transfer
- Provides technical support and feedback loops
- Works with partners to refine tools and protocols based on field performance
Real-World Example
In partnership with regional health authorities, Neftaly transferred a low-cost biomarker-based diagnostic tool for early detection of tuberculosis to rural clinics. Within 18 months:
- Screening coverage increased by 60%
- Positive case detection improved by 35%
- Time to diagnosis dropped from 7 days to under 24 hours
Conclusion
Transferring biomarker technologies to low-resource settings is not just about moving equipment—it’s about empowering systems and people. Neftaly’s holistic, partnership-driven strategies ensure that innovation leads to impact. By bringing science to the frontlines, we help build stronger, more equitable health systems that leave no one behind.